• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Home
  • LinkedIn
  • Twitter

  • About Us
    • Overview
    • Executive Committee
    • Board Of Directors
    • Partners
  • Science
    • Overview
    • Approach
    • Technology
      • shRNA
      • shARC Platform
    • Scientific Publications
  • Pipeline
  • Newsroom
    • Press Releases
    • Events
    • Media Center
  • Investors
    • Overview
    • Analyst Coverage
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Careers
  • Contact Us
  • Home
  • Investors
  • Corporate Governance

Corporate Governance

Corporate Governance

The Company has opted for a one-tier governance structure. The Board of Directors is the ultimate decision-making body of the Company, except with respect to those areas that are reserved by law or by the Company’s Articles of Association to the Shareholders’ Meeting. The corporate governance of the Company is structured pursuant to Belgian Code of the Companies and Associations (the “CCA”), the Company's articles of association, and the Company's corporate governance charter adopted in accordance with the Belgian Corporate Governance Code 2020.

Corporate Governance Charter
Dealing code
Code of Business Conduct and Ethics
Coordinated Articles of Association
Statuts Coordonnés
Board Diversity Matrix

Board Of Directors

The Board of Directors currently consists of nine members. The directors have been appointed at the Shareholders Meeting of the Company. The Board’s composition reflects a diverse and complementary range of experience, nationalities and cultures, ensuring that the interests of all shareholders are taken into account. Members of the BoD are chosen for their skills, their integrity and their independence of mind.

Hilde Windels, Chairwoman

Michel Lussier¹, Executive director

Serge Goblet, Non-executive director

Christopher LiPuma, Non-Executive director

Marina Udier, Independent director

Dominic Piscitelli, Independent director

Ami Patel Shah, Non-Executive director

¹permanent representative of Mel Management SRL

 

Committees of the board of directors

The Board of Directors has set up committees to analyze and advise the Board of Directors on specific matters. Such committees are advisory bodies only and the decision-making remains the collegiate responsibility of the Board of Directors.

The Board of Directors has set-up a Nomination and Remuneration Committee composed of Hilde Windels (Chairwoman), Chris LiPuma and Dominic Piscitelli.

The Board of Directors has set-up an Audit Committee composed of Dominic Piscitelli (Chairman), Marina Udier and Hilde Windels.

Executive COMMITTEE

The Board of Directors has established an Executive Committee composed of the "Chief Executive officer" (CEO), the "Vice President Human Resources", the "Head of Legal", the "Vice President of Finance and Administration" the "Head of Intellectual Property" and the "Director of R&D". The Executive Committee discusses and consults with the Board of Directors on the day-to-day management of the Company in accordance with the Company's values, strategy, general policy and budget, as determined by the BoD.

Michel Lussier, Interim Chief Executive Officer

Eytan Breman, Director of R&D

David Georges, VP of Finance and Administration

An Phan, Head of Legal

Philippe Nobels¹, VP of Human Resources

Hannes Iserentant, Head of IP

 

1. Permanent representative of MC Consult SRL

Footer

Celyad Oncology

Celyad Oncology Logo
  • About
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2020 All Rights Reserved.

  • Cookie Policy |
  • Privacy Policy |
  • Terms of Use